Morphological, immunophenotypic and molecular characterization of mature aggressive B-cell lymphomas in Chinese pediatric patients

Leukemia and Lymphoma

Volumn 52, Issue 12, 2011, Pages 2356-2364

  Lu, Beibei ^a   Zhou, Chunju ^b   Yang, Wenping ^c   Huang, Hui ^c   Gao, Zifen ^d   He, Yaoxin ^d   Liu, Hongxiang ^e   Zhou, Xiaoge ^f   Gong, Liping ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Jiangxi Children's Hospital   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

B cell lymphoma; Burkitt lymphoma; Diffuse large B cell lymphoma; Interphase FISH; Pediatrics; Unclassifiable; With features intermediate between diffuse large B cell lymphoma and Burkitt lymphoma

Indexed keywords

BIOLOGICAL MARKER; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; PROTEIN BCL 6; VIRUS RNA;

ADOLESCENT; ARTICLE; B CELL LYMPHOMA; CANCER DIAGNOSIS; CANCER GENETICS; CANCER PATIENT; CELL PROLIFERATION; CHILD; CHINESE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EPSTEIN BARR VIRUS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PEDIATRICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHINA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; LYMPHOMA, B-CELL; MALE; TUMOR MARKERS, BIOLOGICAL;

EID: 82255184020     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.602772     Document Type: Article

References (36)

1. Dave BJ, Weisenburger DD, Higgins CM, et al. Cytogenetics and f uorescence in situ hybridization studies of dif use large B-cell lymphoma in children and young adults. Cancer Genet Cytogenet 2004;153:115-121. (Pubitemid 39592143)
2. Frost M, Newell J, Lones MA, et al. Comparative immunohistochemical analysis of pediatric Burkitt lymphoma and dif use large B-cell lymphoma. Am J Clin Pathol 2004;121:384-392. (Pubitemid 38298172)
3. Lones MA, Raphael M, Perkins SL, et al. Mature B-cell lymphoma in children and adolescents-international group pathologist consensus correlates with histology technical quality. J Pediatr Hematol Oncol 2006;28:568-574. (Pubitemid 44496333)
4. Oschlies I, Klapper W, Zimmermann M, et al. Dif use large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) multicenter trial. Blood 2006;107:4047-4052. (Pubitemid 43726813)
5. Rosenwald A, Ott G. Burkitt lymphoma versus dif use large B-cell lymphoma. Ann Oncol 2008;19(Suppl. 4):67-69.
6. Chuang SS, Ye H, Du MQ, et al. Histopathology and immunohistochemistry in distinguishing Burkitt lymphoma from dif use large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern: a comparative study with EBER and FISH. Am J Clin Pathol 2007;128:558-564. (Pubitemid 47584432)
7. Zhao X F, Hassan A, Perry A, et al. C-MYC rearrangements are frequent in aggressive mature B-cell lymphoma with atypical morphology. Int J Clin Exp Pathol 2008;1:65-74.
8. Nakamura N, Nakamine H, Tamura J, et al. Te distinction between Burkitt lymphoma and dif use large B-cell lymphoma with c-myc rearrangement. Mod Pathol 2002;15:771-776. (Pubitemid 34787314)
9. Tibiletti MG, Martin V, Bernasconi B, et al. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal dif use large B-cell lymphomas: a multicenter evaluation of a new set of f uorescent in situ hybridization probes and correlation with clinical outcome. Hum Pathol 2009;40:645-652.
10. Leoncini L, Raphael M, Stein H. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization classif cation of tumours. Lyon: IARC Press; 2008.
11. Haralambieva E, Boerma EJ, Van IG, et al. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphological features of Burkitt lymphoma. Am J Surg Pathol 2005;29:1086-1094. (Pubitemid 41045555)
12. Hummel M, Bentink S, Berger H, et al. A biologic def nition of Burkitt's lymphoma from transcriptional and genomic prof ling. N Engl J Med 2006;354:2419-2430. (Pubitemid 43855045)
13. Dave SS, Fu K, Wright GW, et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 2006;354:2431-2442. (Pubitemid 43855046)
14. Day NS, Ayello J, Waxman I, et al. Dif erential gene signature and signaling pathways in childhood Burkitt (BL) vs dif use large B-cell lymphoma (DLBCL). Blood 2007;110(Suppl. 1): Abstract 4142.
15. Akasaka T, Akasaka H, Ueda C, et al. Molecular and clinical features of non-Burkitt's, dif use large-cell lymphoma of B-cell type associated with the c-MYC/immunoglobulin heavy-chain fusion gene. J Clin Oncol 2000;18:510-518. (Pubitemid 30078532)
16. Ruzinova MB, Caron T, Rodig SJ. Altered subcellular localization of c-Myc protein identif es aggressive B-cell lymphomas harboring a c-MYC translocation. Am J Surg Pathol 2010;34:882-891.
17. Klumb CE, Schramm MT, De RL, et al. Treatment of children with B-cell non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil. J Pediatr Hematol Oncol 2004;26:462-468. (Pubitemid 39025263)
18. Anderson JJ, Fordham S, Overman L, et al. Immunophenotyping of dif use large B-cell lymphoma (DLBCL) def nes multiple subgroups of germinal centre-like tumours displaying dif erent survival characteristics. Int J Oncol 2009;35:961-971.
19. Alacacioglu I, Ozcan MA, Ozkal S, et al. Prognostic signif cance of immunohistochemical classif cation of dif use large B-cell lymphoma. Hematology 2009;14:84-89.
20. Gualco G, Weiss LM, Harrington WJ, et al. Nodal dif use large B-cell lymphomas in children and adolescents: immunohistochemical expression patterns and c-MYC translocation in relation to clinical outcome. Am J Surg Pathol 2009;33:1815-1822.
21. Zhang DD, Dong LN, Li HY, et al. Ocular adnexal mucosa-associated lymphoid tissue lymphoma in Northern China: high frequency of numerical chromosomal changes and no evidence of an association with Chlamydia psittaci. Leuk Lymphoma 2010;51: 1951-1953.
22. Weiss LM, Chen YY, Liu XF, et a1. Epstein-Barr virus and Hodgkin's disease: a correlative in situ hybridization and polymerase chain reaction study. Am J Pathol 1991;139:1259-1265.
23. Hans CP, Weisenburger DD, Greiner TC, et al. Conf rmation of the molecular classif cation of dif use large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103: 275-282. (Pubitemid 38029949)
24. Lones MA, Auperin A, Raphael M, et al. Mature B-cell lymphoma/leukemia in children and adolescents: intergroup pathologist consensus with the Revised European-American Lymphoma Classif cation. Ann Oncol 2000;11:47-51. (Pubitemid 30084578)
25. de Leval L, Hasserjian RP. Dif use large B-cell lymphomas and Burkitt lymphoma. Hematol Oncol Clin North Am 2009;23:791-827.
26. Hutchison RE, Finch C, Kepner J, et al. Burkitt lymphoma is immunophenotypically dif erent from Burkitt-like lymphoma in young persons. Ann Oncol 2000;11(Suppl. 1):35-38.
27. Tumwine LK, Campidetti C, Righi S, et al. B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray. Hum Pathol 2008;39:817-823.
28. Gualco G, Queiroga EM, Weiss LM, et al. Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma. Hum Pathol 2009;40:565-571.
29. Chao T Y, Wang TY, Lee WH. Association between Epstein-Barr virus and Burkitt's lymphoma in Taiwan. Cancer 1997;80:121-128.
30. Reiter A, Klapper W. Recent advances in the understanding and management of dif use large B-cell lymphoma in children. Br J Haematol 2008;142:329-347. (Pubitemid 351962165)
31. Miles RR, Raphael M, McCarthy K, et al. Pediatric dif use large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: report of the French-American-British (FAB) international study group. Pediatr Blood Cancer 2008;51:369-374.
32. Bastard C, Deweindt C, Kerckaert JP, et al. LAZ3 rearrangements in non-Hodgkins-lymphoma-correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood 1994;83:2423-2427. (Pubitemid 24135832)
33. Ohno H, Fukuhara S. Signif cance of rearrangement of the BCL6 gene in B-cell lymphoid neoplasms. Leuk Lymphoma 1997;27:53-63. (Pubitemid 27482921)
34. Heerema NA, Sanger WG, Perkins S, et al. High frequency of CMYC rearrangements, 1q21-1q23 duplications and complex karyotypes in B-cell non-Hodgkin lymphoma (NHL) of children and adolescents: a report from Children's Cancer Group (CCG) study CCG-5961. Blood 2002;100(Suppl. 1): Abstract 566.
35. Macpherson N, Lesack D, Klasa R, et al. Small noncleaved, non-Burkitt's (Burkitt-like) lymphoma: cytogenetics predict outcome and reffect clinical presentation. J Clin Oncol 1999;17:1558-1567.
36. Harris NL, Jafe ES, Stein H, et al. A revised European-American classif cation of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392. (Pubitemid 24273002)